In Pain relief Diclotrans 200 Transdermal Patch belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. Take it as it is prescribed to get the most benefit. Do not take more or longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
No interaction found/established
Diclotrans 200 Transdermal Patch may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Diclotrans 200 Transdermal Patch is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
No interaction found/established
Diclotrans 200 Transdermal Patch should be used with caution in patients with kidney disease. Dose adjustment of Diclotrans 200 Transdermal Patch may be needed. Please consult your doctor. Avoid the use of Diclotrans 200 Transdermal Patch in patients with advanced renal disease unless benefits are expected to outweigh the risk of worsening renal function.
Diclotrans 200 Transdermal Patch should be used with caution in patients with liver disease. Dose adjustment of Diclotrans 200 Transdermal Patch may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended in patients with liver disease if this medicine is to be taken for a long time.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Emenox Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alembic Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Karnataka Antibiotics & Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)